Caregiver TouchFree Clinical Thermometer Demand is Driving Record Sales for Sanomedics

MIAMI, Oct. 17, 2014 (GLOBE NEWSWIRE) -- Sanomedics International Holdings, Inc. (OTCQB:SIMH), announced today that demand is soaring for its Caregiver® TouchFree™ Clinical Thermometers, primed by the growing concern for spread of EBOLA and MERS infections. The Company is gearing up for heavy inventory requirements to support this global effort at all healthcare facilities and ports-of-entry.

Caregiver TouchFree Clinical Thermometer

A photo accompanying this release is available at

Keith Houlihan, President of Sanomedics, noted that multiple shipments have been made in recent days to the Centers for Disease Control ("CDC") in Atlanta as well as to other enterprise customers for use in corporate healthcare centers. He went on to indicate that the Company will focus on assisting all segments of the CDC, National Institutes of Health, Department of Homeland Security, and general healthcare facility efforts to reduce the risk of contact/spread of these diseases.

Thermomedics' Vice President of Marketing and Sales, Ron Benincasa, explained that the Caregiver reads only naturally emitted infrared radiation from the subject's body and does NOT employ any "laser" energy as has recently been noted in reports about other, non-clinical grade devices. It is completely safe and clinically proven to be accurate for all ages.

About Sanomedics International Holdings, Inc.

Sanomedics International Holdings, Inc. (OTCQB:SIMH) is a medical technology holding company that focuses on game changing products, services and ideas -- a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. Sanomedics plans to grow existing business organically and through strategic acquisitions specifically relating to healthcare technology and services.

Sign up for Sanomedics email news alert system today at:

Follow Sanomedics on Twitter and tweet us (@Sanomedics) your questions and comments. We would love to hear from you!

Forward Looking Statements

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties (for example, the risk that the acquisition is not consummated), and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The Company's periodic filings with the Securities and Exchange Commission should be viewed for a complete understanding of risk and uncertainty.

CONTACT: Keith Houlihan Sanomedics International Holdings, Inc.

Source:Sanomedics International Holdings, Inc.